Randomised, double-blind, multicentre, mixed-methods, dose-escalation feasibility trial of mirtazapine for better treatment of severe breathlessness in advanced lung disease (BETTER-B feasibility)

New treatments are required for severe breathlessness in advanced disease. We conducted a randomised feasibility trial of mirtazapine over 28 days in adults with a modified medical research council breathlessness scale score ≥3. Sixty-four patients were randomised (409 screened), achieving our prima...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Thorax
Autores principales: Higginson, Irene J, Wilcock, Andrew, Johnson, Miriam J, Bajwah, Sabrina, Lovell, Natasha, Yi, Deokhee, Hart, Simon P, Crosby, Vincent, Poad, Heather, Currow, David, Best, Emma, Brown, Sarah
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Publishing Group 2020
Materias:
Brief Communication
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7029228/
https://ncbi.nlm.nih.gov/pubmed/31915308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thoraxjnl-2019-213879
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares